Biomedical Engineering Reference
In-Depth Information
67. Buyens K, Meyer M, Wagner E, Demeester J, De Smedt SC, Sanders NN (2010) Monitoring
the disassembly of siRNA polyplexes in serum is crucial for predicting their biological
efficacy. J Control Release 141:38-41
68. Kursa M, Walker GF, Roessler V, Ogris M, Roedl W, Kircheis R, Wagner E (2003) Novel
shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic
tumor-targeted gene transfer. Bioconjug Chem 14:222-231
69. Walker GF, Fella C, Pelisek J, Fahrmeir J, Boeckle S, Ogris M, Wagner E (2005) Toward
synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly
enhances gene transfer in vitro and in vivo. Mol Ther 11:418-425
70. Malek A, Czubayko F, Aigner A (2008) PEG grafting of polyethylenimine (PEI) exerts
different effects on DNA transfection and siRNA-induced gene targeting efficacy. J Drug
Target 16:124-139
71. Zhang X, Pan SR, Hu HM, Wu GF, Feng M, Zhang W, Luo X (2008) Poly(ethylene glycol)-
block-polyethylenimine copolymers as carriers for gene delivery: effects of PEG molecular
weight and PEGylation degree. J Biomed Mater Res A 84:795-804
72. Brus C, Petersen H, Aigner A, Czubayko F, Kissel T (2004) Physicochemical and biological
characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a
delivery system for oligonucleotides and ribozymes. Bioconjug Chem 15:677-684
73. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG (2006) PEG conjugated VEGF siRNA for
anti-angiogenic gene therapy. J Control Release 116:123-129
74. Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY (2009) Efficient delivery
of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA
expression level and sensitizing cancer cells to anticancer drug. Biomacromolecules
10:41-48
75. Kircheis R, Schuller S, Brunner S, Ogris M, Heider KH, Zauner W, Wagner E (1999)
Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med
1:111-120
76. Fella C, Walker GF, Ogris M, Wagner E (2008) Amine-reactive pyridylhydrazone-based
PEG reagents for pH-reversible PEI polyplex shielding. Eur J Pharm Sci 34:309-320
77. Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T
(2009) Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral
siRNA delivery. J Control Release 140:284-293
78. Finsinger D, Remy JS, Erbacher P, Koch C, Plank C (2000) Protective copolymers for
nonviral gene vectors: synthesis, vector characterization and application in gene delivery.
Gene Ther 7:1183-1192
79. Rudolph C, Schillinger U, Plank C, Gessner A, Nicklaus P, Muller R, Rosenecker J (2002)
Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified
polyethylenimine 1. Biochim Biophys Acta 1573:75
80. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E (1999) PEGylated DNA/transferrin-
PEI complexes: reduced interaction with blood components, extended circulation in blood
and potential for systemic gene delivery. Gene Ther 6:595-605
81. Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Buyens K, Sanders NN, De Smedt SC, Behe
M, Kissel T (2009) Stability of siRNA polyplexes from poly(ethylenimine) and poly
(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics
and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon
Emission Computed Tomography (SPECT) imaging. J Control Release 138:148-159
82. Fisher KD, Ulbrich K, Subr V, Ward CM, Mautner V, Blakey D, Seymour LW (2000) A
versatile system for receptor-mediated gene delivery permits increased entry of DNA into
target cells, enhanced delivery to the nucleus and elevated rates of transgene expression.
Gene Ther 7:1337-1343
83. Carlisle RC, Etrych T, Briggs SS, Preece JA, Ulbrich K, Seymour LW (2004) Polymer-coated
polyethylenimine/DNA complexes designed for triggered activation by intracellular reduc-
tion. J Gene Med 6:337-344
